Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease
Clinical trial NCT04209712 · UNKNOWN
Trial details
- NCT number
- NCT04209712
- Sponsor
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2020-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.